Replimune Group's RP1 oncolytic virus therapy faced an FDA rejection, raising concerns about the platform's viability in ...

"The monthly installments, if taken for 20 years, are approximately Rp1 million. This already includes fire, credit, and life insurance," said Heru. Minister of Home Affairs Muhammad Tito Karnavian ...

WOBURN, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today ...

George Tidmarsh takes over temporarily at CBER following Vinay Prasad’s abrupt departure; Replimmune trial leaders protest ...

President Prabowo Subianto instructed Health Minister Budi Gunadi Sadikin to increase the number of dentists at public health ...

GoTo had a connection to the procurement process and mechanisms for Google Cloud at Kemendikbudristek during that time.

PT Teladan Prima Agro Tbk (TLDN) delivered stellar results in the first half of 2025, booking a net profit of Rp561.28 billion ...

In an open letter, 22 experts who designed and ran Replimmune’s Phase III IGNYTE trial answered the FDA’s issues, as outlined ...

PT Pradiksi Gunatama Tbk (PGUN), a palm oil company owned by Indonesian tycoon Andi Syamsuddin Arsyad (popularly known as ...

Hearing minnow Audeara has entered an alliance with Ear Science Institute Australia to develop an affordable bone conduction hearing device.